M&A Deal Summary

Zoetis Acquires Bovigen

On March 18, 2008, Zoetis acquired life science company Bovigen

Acquisition Highlights
  • This is Zoetis’ 3rd transaction in the Life Science sector.
  • This is Zoetis’ 2nd transaction in the United States.
  • This is Zoetis’ 1st transaction in Louisiana.

M&A Deal Summary
Date 2008-03-18
Target Bovigen
Sector Life Science
Buyer(s) Zoetis
Deal Type Add-on Acquisition

Target

Bovigen

Harahan, Louisiana, United States
Bovigen, LLC, based in Harahan, Louisiana, is a global genetic technology company that markets and services Catapult Genetic’s products throughout the Americas.

Search 192,297 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zoetis

Parsippany, New Jersey, United States

website

Category Company
Founded 1952
Sector Life Science
Employees11,300
Revenue 6.7B USD (2020)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 3 of 13
Sector (Life Science) 3 of 7
Type (Add-on Acquisition) 3 of 12
State (Louisiana) 1 of 1
Country (United States) 2 of 8
Year (2008) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-18 Catapult Genetics Pty.

Albion, Australia

Catapult is a global provider of sheep and cattle DNA testing technologies for meat and carcass quality and production efficiency under the GeneSTAR® Quality Grade, Feed Efficiency, the SureTRAK® system, and the SireTRACETM product brands. In addition to co-founders Gerard Davis and Jay Hetzel, shareholders include AgResearch, CSIRO, Kestrel Capital’s Nanyang Innovation Fund, and Meat & Wool New Zealand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-10 PHARMAQ Holding AS

Overhalla, Norway

PHARMAQ Holding AS is a pharmaceutical company focused on aquaculture. It develops, manufactures and markets vaccines and therapeutic products for the prevention and treatment of diseases in farmed fish.

Buy $765M
Mergr

Product

Company

Legal